Insights into Mechanisms and Models for Studying Neurological Adverse Events Mediated by Pharmacokinetic Interactions between Clinical Drugs and Illicit Substances of Herbal and Fungal Origin

Salamat, JM and Abbott, KL and Gill, KS and Flannery, PC and Biancardi, VC and Boothe, DM and Huang, C-CJ and Mani, S and Chandran, A and Vishveshwara, S and Onteru, SK and Dhanasekaran, M and Pondugula, SR (2021) Insights into Mechanisms and Models for Studying Neurological Adverse Events Mediated by Pharmacokinetic Interactions between Clinical Drugs and Illicit Substances of Herbal and Fungal Origin. [Book Chapter]

PDF med_her_fun_137-158_2021.pdf - Published Version Restricted to Registered users only Download (706kB) | Request a copy

Abstract

Coadministration of herbs and fungi with clinical drugs can result in herb–drug and fungi–drug interactions, leading to adverse effects, including neurological and related adverse events. Many of the illicit substances are derived from herbs or fungi. Hence, adverse neurological events that arise from pharmacokinetics-based interactions of illicit substances of herbal/fungal origin with clinical drugs are of significant health burden. Despite the knowledge that concomitant usage of clinical drugs with illicit substances can often result in neurological and related adverse events, the underlying pharmacokinetics-based mechanisms of these interactions are poorly understood. This chapter briefly highlights the neurological and related adverse events associated with pharmacokinetics-based interactions between clinical drugs and commonly used illicit substances of herbal or fungal origin, such as ayahuasca, cannabis (marijuana), cocaine, psilocybin, khat, salvia, kratom, and mescaline. This chapter discusses a great deal of novel insights into the potential mechanisms of pharmacokinetics-based interactions between clinical drugs and illicit substances of herbal/fungal origin that may be responsible for neurological and related adverse events. Finally, this chapter provides insights into potential experimental models that can be used in studying these pharmacokinetic interactions that lead to neurological adverse events.

Item Type:	Book Chapter
Publication:	Medicinal Herbs and Fungi: Neurotoxicity vs. Neuroprotection
Publisher:	Springer Singapore
Additional Information:	The copyright for this article belongs to Springer Singapore.
Keywords:	Adverse drug interactions; Adverse neurological events; Adverse pharmacokinetic interactions; Drug transporters; Drug-metabolizing enzymes; Illicit substances
Department/Centre:	Division of Biological Sciences > Molecular Biophysics Unit
Date Deposited:	25 Apr 2023 09:06
Last Modified:	25 Apr 2023 09:06
URI:	https://eprints.iisc.ac.in/id/eprint/81401

Actions (login required)

View Item